A carregar...
A Randomised, Double-Blind, Placebo-Controlled Trial of Actovegin in Patients with Post-Stroke Cognitive Impairment: ARTEMIDA Study Design
BACKGROUND: No drug treatment to date has shown convincing clinical evidence of restoring cognitive function or preventing further decline after stroke. The ongoing ARTEMIDA study will evaluate the efficacy and safety of Actovegin for the symptomatic treatment of post-stroke cognitive impairment (PS...
Na minha lista:
Main Authors: | , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
S. Karger AG
2013
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3919431/ https://ncbi.nlm.nih.gov/pubmed/24516413 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000357122 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|